Glucocorticoid receptor: Implications for rheumatic diseases

Clinical and Experimental Rheumatology

Volumn 29, Issue 5 SUPPL. 68, 2011, Pages

  Kino, T ^a   Charmandari, E ^b,c   Chrousos, G P ^b,c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Acetylation; Circadian rhythm; Glucocorticoid receptor; Non genomic action; Splicing isoform; Transcriptional activity

Indexed keywords

GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; TRANSCRIPTION FACTOR;

ARTICLE; CYTOPLASM; DNA SEQUENCE; GENE STRUCTURE; IMMUNE SYSTEM; INFLAMMATORY DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; RHEUMATIC DISEASE; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

HUMANS; ISOMERISM; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, GLUCOCORTICOID; RHEUMATIC DISEASES; TRANSCRIPTIONAL ACTIVATION;

EID: 81155144643     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. CHROUSOS GP: Stress and disorders of the stress system. Nat Rev Endocrinol 2009; 5: 374-81.
2. BOUMPAS DT, CHROUSOS GP, WILDER RL, CUPPS TR, BALOW JE: Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993; 119: 1198-208. (Pubitemid 23361450)
3. MANGELSDORF DJ, THUMMEL C, BEATO M et al.: The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835-9.
4. KINO T, CHROUSOS GP: Glucocorticoid and mineralocorticoid receptors and associated diseases. Essays Biochem 2004; 40:137-55. (Pubitemid 38901170)
5. GALON J, FRANCHIMONT D, HIROI N et al.: Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002; 16: 61-71. (Pubitemid 34027951)
6. KINO T, ICHIJO T, AMIN ND et al.: Cyclindependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol 2007; 21: 1552-68. (Pubitemid 47001081)
7. HOLLENBERG SM, WEINBERGER C, ONG ES et al.: Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985; 318: 635-41. (Pubitemid 16172412)
8. BAMBERGER CM, BAMBERGER AM, DE CASTRO M, CHROUSOS GP: Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995; 95: 2435-41.
9. KINO T, SU YA, CHROUSOS GP: Human glucocorticoid receptor isoform β: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci 2009; 66: 3435-48.
10. LU NZ, CIDLOWSKi JA: Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 2005; 18:331-42. (Pubitemid 41350538)
11. PRESUL E, SCHMIDT S, KOFLER R, HELMBERG A: Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor. J Mol Endocrinol 2007; 38: 79-90. (Pubitemid 46351594)
12. TURNER JD, MULLER CP: Structure of the glucocorticoid receptor (NR3C1) gene 5' untranslated region: identification, and tissue distribution of multiple new human exon 1. J Mol Endocrinol 2005; 35: 283-92. (Pubitemid 41556176)
13. ALMLOF T, GUSTAFSSON JA, WRIGHT AP: Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol Cell Biol 1997; 17: 934-45. (Pubitemid 27044392)
14. ALMLOF T, WALLBERG AE, GUSTAFSSON JA, WRIGHT AP: Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors. Biochemistry 1998; 37: 9586-94. (Pubitemid 28307715)
15. WARNMARK A, GUSTAFSSON JA, WRIGHT AP: Architectural principles for the structure and function of the glucocorticoid receptor tau 1 core activation domain. J Biol Chem 2000; 275: 15014-8. (Pubitemid 30337220)
16. KINO T: Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids. Horm Metab Res 2007; 39: 420-4. (Pubitemid 46999848)
17. LUISI BF, XU WX, OTWINOWSKI Z, FREEDMAN LP, YAMAMOTO KR, SIGLER PB: Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991;352:497-505. (Pubitemid 21912367)
18. BLEDSOE RK, MONTANA VG, STANLEY TB et al.: Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 2002; 110: 93-105. (Pubitemid 34874609)
19. TANENBAUM DM, WANG Y, WILLIAMS SP, SIGLER PB: Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 1998;95:5998-6003. (Pubitemid 28248953)
20. WILLIAMS SP, SIGLER PB: Atomic structure of progesterone complexed with its receptor. Nature 1998; 393: 392-6. (Pubitemid 28269716)
21. CHROUSOS GP, KINO T: Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005; 2005: pe48.
22. YUDT MR, JEWELL CM, BIENSTOCK RJ, CIDLOWSKI JA: Molecular origins for the dominant negative function of human glucocorticoid receptor β. Mol Cell Biol 2003; 23:4319-30. (Pubitemid 36666433)
23. HOWARD KJ, HOLLEY SJ, YAMAMOTO KR, DISTELHORST CW: Mapping the HSP90 binding region of the glucocorticoid receptor. J Biol Chem 1990; 265: 11928-35.
24. DENIS M, GUSTAFSSON JA, WIKSTROM AC: Interaction of the Mr = 90,000 heat shock protein with the steroid-binding domain of the glucocorticoid receptor. J Biol Chem 1988; 263: 18520-3. (Pubitemid 19005130)
25. CZAR MJ, LYONS RH, WELSH MJ, RENOIR JM, PRATT WB: Evidence that the FK506-binding immunophilin heat shock protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol Endocrinol 1995; 9: 1549-60.
26. OWENS-GRILLO JK, HOFFMANN K, HUTCHISON KA et al.: The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J Biol Chem 1995; 270: 20479-84.
27. SAVORY JG, HSU B, LAQUIAN IR et al.: Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol Cell Biol 1999; 19: 1025-37. (Pubitemid 29046846)
28. LANGE A, MILLS RE, LANGE CJ, STEWART M, DEVINE SE, CORBETT AH: Classical nuclear localization signals: definition, function, and interaction with importin a. J Biol Chem 2007; 282: 5101-5. (Pubitemid 47093710)
29. BOLDIZSAR F, TALABER G, SZABO M et al.: Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells. Immunobiology 2010; 215: 521-6.
30. HACHE RJ, TSE R, REICH T, SAVORY JG, LEFEBVRE YA: Nucleocytoplasmic trafficking of steroid-free glucocorticoid receptor. J Biol Chem 1999; 274: 1432-9.
31. YANG J, LIU J, DEFRANCO DB: Subnuclear trafficking of glucocorticoid receptors in vitro: chromatin recycling and nuclear export. J Cell Biol 1997; 137: 523-38. (Pubitemid 27200658)
32. DEFRANCO DB: Subnuclear trafficking of steroid receptors. Biochem Soc Trans 1997; 25: 592-7. (Pubitemid 27260878)
33. HOLASKA JM, BLACK BE, LOVE DC, HANOVER JA, LESZYK J, PASCHAL BM: Calreticulin Is a receptor for nuclear export. J Cell Biol 2001; 152: 127-40. (Pubitemid 32102442)
34. BLACK BE, HOLASKA JM, RASTINEJAD F, PASCHAL BM: DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr Biol 2001; 11: 1749-58. (Pubitemid 33098556)
35. HOLASKA JM, BLACK BE, RASTINEJAD F, PASCHAL BM: Ca2+-dependent nuclear export mediated by calreticulin. Mol Cell Biol 2002; 22: 6286-97. (Pubitemid 34857846)
36. KINO T, SOUVATZOGLOU E, DE MARTINO MU, TSOPANOMIHALU M, WAN Y, CHROUSOS GP: Protein 14-3-3σ interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway. J Biol Chem 2003;278:25651-6. (Pubitemid 36835319)
37. LIEBERMAN BA, BONA BJ, EDWARDS DP, NORDEEN SK: The constitution of a progesterone response element. Mol Endocrinol 1993;7:515-27. (Pubitemid 23138161)
38. GOULDING NJ: The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus. Curr Opin Pharmacol 2004; 4: 629-36. (Pubitemid 40267879)
39. ROSENFELD MG. LUNYAK VV, GLASS CK: Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 2006; 20: 1405-28. (Pubitemid 43830648)
40. MCKENNA NJ, LANZ RB. O'MALLEY BW: Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 1999; 20: 321-44. (Pubitemid 30649811)
41. REICHARDT HM, KAESTNER KH, TUCKERMANN J et al.: DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998; 93: 531-41. (Pubitemid 28240715)
42. COLE TJ, BLENDY JA, MONAGHAN AP et al.: Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995; 9: 1608-21.
43. REICHARDT HM, TUCKERMANN JP, GOTTLICHER M et al.: Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 2001;20:7168-73. (Pubitemid 34062308)
44. MINER JN, YAMAMOTO KR: Regulatory crosstalk at composite response elements. Trends Biochem Sci 1991; 16: 423-6. (Pubitemid 121004486)
45. KARIN M, CHANG L: AP-1-glucocorticoid receptor crosstalk taken to a higher level. J Endocrinol 2001; 169: 447-51. (Pubitemid 32536977)
46. BARNES PJ, KARIN M: Nuclear factor-KB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-71. (Pubitemid 27163860)
47. DIDONATO JA, SAATCIOGLU F, KARIN M: Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Am J Respir Crit Care Med 1996; 154: S11-5. (Pubitemid 26269079)
48. ICHIJO T, VOUTETAKIS A, COTRIM AP et al.: The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications. J Biol Chem 2005; 280: 42067-77. (Pubitemid 43023176)
49. LIBERMAN AC, DRUKER J, GARCIA FA, HOLSBOER F, ARZT E: Intracellular molecular signaling. Basis for specificity to glucocorticoid anti-inflammatory actions. Ann N Y Acad Sci 2009; 1153:6-13.
50. LIBERMAN AC, REFOJO D, DRUKER J et al.: The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J 2007; 21: 1177-88. (Pubitemid 46495707)
51. REILY MM, PANTOJA C, HU X, CHINENOV Y, ROGATSKY I: The GRIP1: IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J 2006; 25: 108-17. (Pubitemid 43077300)
52. KINO T, CHROUSOS GP: Tumor necrosis factor a receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators. J Biol Chem 2003; 278: 3023-9. (Pubitemid 36801210)
53. KINO T, ICHIJO T, CHROUSOS GP: FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors. J Steroid Biochem Mol Biol 2004; 92: 357-63. (Pubitemid 40187153)
54. BARTHOLOME B, SPIES CM, GABER T et al.: Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J 2004;18:70-80. (Pubitemid 38076467)
55. SPIES CM, SCHAUMANN DH, BERKI T et al.: Membrane glucocorticoid receptors are down regulated by glucocorticoids in patients with systemic lupus erythematosus and use a caveolin-1-independent expression pathway. Ann Rheum Dis 2006; 65: 1139-46. (Pubitemid 44277386)
56. EVANS SJ, SEARCY BT, MOORE FL: A subset of κ opioid ligands bind to the membrane glucocorticoid receptor in an amphibian brain. Endocrinology 2000; 141: 2294-300. (Pubitemid 32269047)
57. ZHU Y, RICE CD, PANG Y, PACE M, THOMAS P: Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 2003; 100: 2231-6. (Pubitemid 36297482)
58. KAJI DM, THAKKAR U, KAHN T: Glucocorticoid-induced alterations in the sodium potassium pump of the human erythrocyte. J Clin Invest 1981; 68: 422-30. (Pubitemid 11039621)
59. STAHN C, BUTTGEREIT F: Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 2008; 4: 525-33.
60. LOWENBERG M, TUYNMAN J, BILDERBEEK J et al.: Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 2005; 106: 1703-10. (Pubitemid 41208584)
61. LOWENBERG M, VERHAAR AP, VAN DEN BRINK GR, HOMMES DW: Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol Med 2007; 13: 158-63. (Pubitemid 46498830)
62. LOWENBERG M, VERHAAR AP, BILDERBEEK J et al.: Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep 2006; 7: 1023-9. (Pubitemid 44480518)
63. HARR MW, RONG Y, BOOTMAN MD, RODERICK HL, DISTELHORST CW: Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors. J Biol Chem 2009;284:31860-71.
64. SIONOV RV, COHEN O, KFIR S, ZILBERMAN Y, YEFENOF E: Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis. J Exp Med 2006; 203: 189-201. (Pubitemid 43139657)
65. SIONOV RV, KFIR S, ZAFRIR E, COHEN O, ZILBERMAN Y, YEFENOF E: Glucocorticoidinduced apoptosis revisited: a novel role for glucocorticoid receptor translocation to the mitochondria. Cell Cycle 2006; 5: 1017-26. (Pubitemid 43778733)
66. PSARRA AM, SEKERIS CE: Glucocorticoid receptors and other nuclear transcription factors in mitochondria and possible functions. Biochim Biophys Acta 2009; 1787: 431-6.
67. KINO T, DE MARTINO MU, CHARMANDARI E, MIRANI M, CHROUSOS GP: Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol 2003; 85: 457-67. (Pubitemid 37011122)
68. KINO T, CHROUSOS GP: Virus-mediated modulation of the host endocrine signaling systems: clinical implications. Trends Endocrinol Metab 2007; 18: 159-66. (Pubitemid 46617272)
69. GOLEVA E, LI LB, EVES PT, STRAND MJ, MARTIN RJ, LEUNG DY: Increased glucocorticoid receptor β alters steroid response in glucocorticoid- insensitive asthma. Am J Respir Crit Care Med 2006; 173: 607-16. (Pubitemid 43363801)
70. DERIJK RH, SCHAAF MJ, TURNER G et al.: A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor β-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 2001; 28: 2383-8. (Pubitemid 33031964)
71. LEE CK, LEE EY, CHO YS, MOON KA, YOO B, MOON HB: Increased expression of glucocorticoid receptor β messenger RNA in patients with ankylosing spondylitis. Korean J Intern Med 2005; 20: 146-51. (Pubitemid 43109897)
72. LONGUI CA, VOTTERO A, ADAMSON PC et al.: Low glucocorticoid receptor α/β ratio in T-cell lymphoblastic leukemia. Horm Metab Res 2000; 32: 401-6.
73. PUJOLS L, MULLOL J, BENITEZ P et al.: Expression of the glucocorticoid receptor a and β isoforms in human nasal mucosa and polyp epithelial cells. Respir Med 2003; 97: 90-6. (Pubitemid 36109119)
74. SHAHIDI H, VOTTERO A, STRATAKIS CA et al.: Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem Biophys Res Commun 1999;254:559-65. (Pubitemid 29290505)
75. PIOTROWSKI P, BURZYNSKI M, LIANERI M et al.: Glucocorticoid receptor β splice variant expression in patients with high and low activity of systemic lupus erythematosus. Folia Histochem Cytobiol 2007; 45: 339-42. (Pubitemid 351193607)
76. LEUNG DY, HAMID Q, VOTTERO A et al.: Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J Exp Med 1997; 186: 1567-74. (Pubitemid 27479816)
77. WEBSTER JC, OAKLEY RH, JEWELL CM, CIDLOWSKI JA: Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 2001; 98: 6865-70. (Pubitemid 32538308)
78. XU Q, LEUNG DY, KISICH KO: Serine-arginine-rich protein p30 directs alternative splicing of glucocorticoid receptor pre-mRNA to glucocorticoid receptor β in neutrophils. J Biol Chem 2003; 278: 27112-8. (Pubitemid 36876866)
79. STRICKLAND I, KISICH K, HAUK PJ et al.: High constitutive glucocorticoid receptor β in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 2001; 193:585-93. (Pubitemid 32539555)
80. ORII F, ASHIDA T, NOMURA M et al.: Quantitative analysis for human glucocorticoid receptor α/β mRNA in IBD. Biochem Biophys Res Commun 2002; 296: 1286-94.
81. TLIBA O, DAMERA G, BANERJEE A et al.: Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1. Am J Respir Cell Mol Biol 2008; 38: 463-72. (Pubitemid 351758693)
82. CHUNG CC, SHIMMIN L, NATARAJAN S, HANIS CL, BOERWINKLE E, HIXSON JE: Glucocorticoid receptor gene variant in the 3' untranslated region is associated with multiple measures of blood pressure. J Clin Endocrinol Metab 2009; 94: 268-76.
83. CHARMANDARI E, CHROUSOS GP, ICHIJO T et al.: The human glucocorticoid receptor (hGR) β isoform suppresses the transcriptional activity of hGRct by interfering with formation of active coactivator complexes. Mol Endocrinol 2005; 19:52-64. (Pubitemid 40065958)
84. OAKLEY RH, JEWELL CM, YUDT MR, BOFETIADO DM, CIDLOWSKI JA: The dominant negative activity of the human glucocorticoid receptor β isoform. Specificity and mechanisms of action. J Biol Chem 1999; 274: 27857-66.
85. KINO T, SU YA, CHROUSOS GP: Human glucocorticoid receptor isoform β: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol Life Sci 2009; 66: 3435-48.
86. KINO T, MANOLI I, KELKAR S, WANG Y, SU YA, CHROUSOS GP: Glucocorticoid receptor (GR) β has intrinsic, GRα-independent transcriptional activity. Biochem Biophys Res Commun 2009; 381: 671-5.
87. LEWIS-TUFFIN U, JEWELL CM, BIENSTOCK RJ, COLLINS JB, CIDLOWSKI JA: Human glucocorticoid receptor β binds RU-486 and is transcriptionally active. Mol Cell Biol 2007; 27: 2266-82. (Pubitemid 46418481)
88. STRAUB RH, CUTOLO M: Orcadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 2007; 56: 399-408.
89. SPIES CM, CUTOLO M, STRAUB RH, BURMESTER GR, BUTTGEREIT F: More night than day - circadian rhythms in polymyalgia rheumatica and ankylosing spondylitis. J Rheumatol 2010; 37: 894-9.
90. CROFFORD LJ, KALOGERAS KT, MASTORAKOS G et al.: Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 1997; 82: 1279-83. (Pubitemid 27166676)
91. BUTTGEREIT F, DOERING G, SCHAEFFLER A et al.: Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 2008; 371: 205-14.
92. ARVIDSON NG, GUDBJORNSSON B, LARSSON A, HALLGREN R: The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis 1997; 56: 27-31. (Pubitemid 27060569)
93. TAKAHASHI JS, HONG HK, KO CH, MCDEARMON EL: The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 2008; 9: 764-75.
94. NADER N, CHROUSOS GP, KINO T: Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol Metab 2010;21:277-86.
95. NADER N, CHROUSOS GP, KINO T: Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications. FASEB J 2009; 23: 1572-83.
96. CHARMANDARI E, LAMBROU GI, PAVLAKI A et al.: Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. Plos One 2011; (in press).
97. KINO T, CHARMANDARI E, CHROUSOS GP: Endotext.org: Glucocorticoid receptor. DE DROOT LJ (Ed.), South Dartmouth, MD-Text.com, Inc., 2010.
98. KINO T, CHROUSOS GP: Tissue-specific glucocorticoid resistance- hypersensitivity syndromes: multifactorial states of clinical importance. J Allergy Clin Immunol 2002; 109:609-13. (Pubitemid 34327185)
99. DE BOSSCHER K, HAEGEMAN G: Minireview: latest perspectives on antiinflammatory actions of glucocorticoids. Mol Endocrinol 2009; 23: 281-91.
100. BECK IM, VANDEN BERGHE W, VERMEULEN L, YAMAMOTO KR, HAEGEMAN G, DE BOSSCHER K: Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev 2009; 30: 830-82.
101. MARTENS C, BILODEAU S, MAIRA M, GAUTHIER Y, DROUIN J: Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol Endocrinol 2005; 19: 885-97. (Pubitemid 40397054)